Par Drugs and Chemicals Ltd
PAR
Company Profile
Business description
Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage. The company is dealing in only one segment i.e. manufacturing industry, API.
Contact
Gotri Vasna Road
816, Nilamber Triumph
VadodaraGJ390007
INDT: +91 265 2991022
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
122
Stocks News & Analysis
stocks
Our top ASX picks in every sector
These companies are our top choices for investors wanting to boost Aussie exposure.
stocks
Potentially catastrophic ruling for ASX company
We raise our risk and uncertainty rating to reflect the impact of the ruling.
stocks
4 charts on Nvidia’s record $4 trillion market cap
Shares of the semiconductor giant have rocketed 280% over the past two years amid the AI boom.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,858.00 | 42.70 | 0.48% |
| CAC 40 | 7,808.17 | 21.12 | -0.27% |
| DAX 40 | 24,160.64 | 94.67 | -0.39% |
| Dow JONES (US) | 44,459.65 | 88.14 | 0.20% |
| FTSE 100 | 8,998.06 | 56.94 | 0.64% |
| HKSE | 24,243.39 | 40.07 | 0.17% |
| NASDAQ | 20,640.33 | 54.80 | 0.27% |
| Nikkei 225 | 39,492.16 | 32.54 | 0.08% |
| NZX 50 Index | 12,675.36 | 3.33 | -0.03% |
| S&P 500 | 6,268.56 | 8.81 | 0.14% |
| S&P/ASX 200 | 8,614.80 | 44.40 | 0.52% |
| SSE Composite Index | 3,486.88 | 32.77 | -0.93% |